Categories: Business

Adidas Splits Tank After Warning About Unsold Yeezy Inventory

“The numbers speak for themselves. We are currently not performing as we should,” said Adidas CEO Bjørn Gulden in a press release.

Jeremy Moeller/Staff/Getty Images

Adidas could lose around €1.2 billion ($1.3 billion) in revenue in 2023 if it’s unable to sell its existing Yeezy stock.

The German sportswear company canceled its partnership with rapper and fashion designer Ye, formerly known as Kanye West, the face of Yeezy, in October after he made a series of anti-Semitic comments.

related investment news

The company said late Thursday it was reviewing what to do with the inventory, adding it had already considered the “significant negative impact” of not selling the products.

Operating profit would fall by around 500 million euros if the company doesn’t switch products, and Adidas expects sales to fall in the high single digits in 2023. Adidas could choose to write off its remaining Yeezy products.

Shares fell 9.5% on Friday morning as traders reacted to the announcements.

The company also forecast one-off costs of up to 200 million euros, leaving Adidas’ worst-case scenario for the year at a loss of 700 million euros for 2023.

“The numbers speak for themselves. We are not currently performing as we should,” Adidas CEO Bjørn Gulden said in a press release.

Adidas’ revenues increased by 1% in 2022 based on unaudited figures, while operating profit fell to 669 million euros in 2022 from almost 2 billion euros in 2021.

Jimmy Page

MV Telegraph Writer Jimmy Page has been writing for all these 37 years.

Recent Posts

Why Multifamily Properties Are a Smart Play for Real Estate Investors in 2026

Picture this: a bustling apartment complex filled with tenants who reliably pay rent every month.…

2 months ago

Metformin for Longevity: Understanding Its Anti-Aging Potential

Metformin has been used for decades. Not as a wellness trend. Not as a supplement…

2 months ago

Ashton Kutcher returns to appearing in The Magnificence

Ashton Kutcher does not bother anyone with this beauty treatment. At least the company doesn't.…

2 months ago

First GLP-1 anti-obesity capsule from Novo Nordisk launches within the US

The logo of pharmaceutical company Novo Nordisk is seen outside its offices in Bagsvaerd on…

2 months ago

The petty and infantile purpose Trump will not permit Machado to steer Venezuela

Donald Trump is by far the pettiest president in US history. He never forgets an…

2 months ago

Protection Shares Rise; The US assault on Venezuela heralds the period of “laborious energy”.

Defense stocks in Europe and Asia rose sharply on Monday as investors gauged that the…

2 months ago

This website uses cookies.